Genistein-induced neuroendocrine differentiation of prostate cancer cells
- 1 May 2006
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 66 (11) , 1136-1143
- https://doi.org/10.1002/pros.20440
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activityInternational Journal of Urology, 2005
- Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy menThe American Journal of Clinical Nutrition, 2002
- Legumes and soybeans: overview of their nutritional profiles and health effectsThe American Journal of Clinical Nutrition, 1999
- Neuroendocrine differentiation in prostatic carcinomaThe Prostate, 1999
- 5Epidemiology of phytoestrogensBailliere's Clinical Endocrinology and Metabolism, 1998
- 10 Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo dataBailliere's Clinical Endocrinology and Metabolism, 1998
- Mechanism for the Suppression of the Mammalian Stress Response by Genistein, an Anticancer Phytoestrogen From SoyJNCI Journal of the National Cancer Institute, 1998
- Antioxidant and Antipromotional Effects of the Soybean Isoflavone GenisteinExperimental Biology and Medicine, 1995
- Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancerJournal of Cellular Biochemistry, 1995
- Soy intake and cancer risk: A review of thein vitroandin vivodataNutrition and Cancer, 1994